New Triple Therapy for Chronic Hepatitis C: Real Life Clinical Experience in a Community Setting

Recent advances in treatment of chronic hepatitis C virus have improved significantly due to the introduction of two new protease inhibitors—telaprevir and boceprevir. In combination with the previous standard of care, peginterferon and ribavirin, telaprevir and boceprevir have demonstrated improved...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Akiyama, Matthew J, Piotrowski, Joy I, Roytman, Marina M, Chan, Siu MA, Hong, Leena K, Huddleston, Leslie, Trujillo, Ruby, Tsai, Naoky CS
Formato: Artigo
Idioma:Inglês
Publicado: University Clinical, Education & Research Associate (UCERA) 2013
Assuntos:
American College of Physicians, Hawai‘i Chapter; Annual Meeting 2013
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3764547/
https://ncbi.nlm.nih.gov/pubmed/24052911
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares